Effect of Sasa quelpaertensis Nakai extract consumption on body fat reduction in obesity adults

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000654

Enrollment

Registered

2013-02-04

Start date

2012-11-19

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : consumption of placebo or Sasa quelpaertensis Nakai extract(1g or 2g) for 12 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Voluntarily agree to participate and sign in informed consent form 2) Men or women aged 20-65 years 3) BMI: 25kg/m2 = ~ = 35kg/m2

Exclusion criteria

Exclusion criteria: 1) Continuous consumption of antiobesity drugs(absorption inhibitors, antidepressants, anorexing agents), diuretic, contraceptive, steroids, female hormone that affect body weight 2) Continuous consumption of dietary supplement or oriental medicine within 4 weeks before the first visit 3) Consumption of dietary supplement for body weight control or participation in commercial obesity program within 8 weeks before first visit 4) Expereienced with surgery like bowel resection for weight loss 5) Following diseases: ? Uncontrolled hypertension (=140/90mmHg) ? Diabetes (fasting blood glucose =126 mg/dL) ? Liver dysfunction (AST, ALT = 2.5 times of the upper limit of normal level) ? Renal dysfunction(Creatinine=1.2mg/dL) ? Hyperthiroidism and hypothyroidism ? Malignant tumors 6) Hypersensitivity to Sasa quelpaertensis Nakai 7) Participation of another clinical trials within 4 weeks before the first visit 8) Pregnant or lactating women 9) Any condition that the principal investigator belives may put the subjects at undue risk

Design outcomes

Primary

Measure	Time frame
body fat-related biomarkers	—

Secondary

Measure	Time frame
lipid profile	—

Countries

Korea, Republic of

Contacts

Public ContactKyungwon Shim

Ewha Womans University Medical Center

Outcome results